These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 26031304)

  • 1. Effects of Cancer Therapy Targeting Vascular Endothelial Growth Factor Receptor on Central Blood Pressure and Cardiovascular System.
    Moreo A; Vallerio P; Ricotta R; Stucchi M; Pozzi M; Musca F; Meani P; Maloberti A; Facchetti R; Di Bella S; Giganti MO; Sartore-Bianchi A; Siena S; Mancia G; Giannattasio C
    Am J Hypertens; 2016 Feb; 29(2):158-62. PubMed ID: 26031304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient-specific blood pressure correction technique for arterial stiffness: evaluation in a cohort on anti-angiogenic medication.
    Spronck B; Delhaas T; De Lepper AG; Giroux J; Goldwasser F; Boutouyrie P; Alivon M; Reesink KD
    Hypertens Res; 2017 Aug; 40(8):752-757. PubMed ID: 28298652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Role of VEGFR-TKIs in the treatment of renal cell carcinoma].
    Kondo T
    Nihon Jinzo Gakkai Shi; 2012; 54(5):574-80. PubMed ID: 22991835
    [No Abstract]   [Full Text] [Related]  

  • 4. Sarcomatoid dedifferentiation in metastatic clear cell renal cell carcinoma and outcome on treatment with anti-vascular endothelial growth factor receptor tyrosine kinase inhibitors: a retrospective analysis.
    Beuselinck B; Lerut E; Wolter P; Dumez H; Berkers J; Van Poppel H; Joniau S; Oyen R; De Wever L; Strijbos M; Paridaens R; Schöffski P
    Clin Genitourin Cancer; 2014 Oct; 12(5):e205-14. PubMed ID: 24861951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arterial wave reflection during antihypertensive therapy with barnidipine: a 6-month, open-label study using an integrated cardiovascular ultrasound approach in patients with newly diagnosed hypertension.
    Palombo C; Malshi E; Morizzo C; Rakebrandt F; Corretti V; Santini F; Fraser AG; Kozakova M
    Clin Ther; 2009 Dec; 31(12):2873-85. PubMed ID: 20110026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term outcomes of tyrosine kinase inhibitor discontinuation in patients with metastatic renal cell carcinoma.
    Koo DH; Park I; Ahn JH; Lee DH; You D; Jeong IG; Song C; Hong B; Hong JH; Ahn H; Lee JL
    Cancer Chemother Pharmacol; 2016 Feb; 77(2):339-47. PubMed ID: 26687171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Visit-to-visit variability in systolic blood pressure: correlated with the changes of arterial stiffness and myocardial perfusion in on-treated hypertensive patients.
    Song H; Wei F; Liu Z; Zhao Y; Ye L; Lu F; Zhang H; Diao Y; Qi Z; Xu J
    Clin Exp Hypertens; 2015; 37(1):63-9. PubMed ID: 24678998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors and model for predicting toxicity-related treatment discontinuation in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor-targeted therapy: Results from the International Metastatic Renal Cell Carcinoma Database Consortium.
    Kaymakcalan MD; Xie W; Albiges L; North SA; Kollmannsberger CK; Smoragiewicz M; Kroeger N; Wells JC; Rha SY; Lee JL; McKay RR; Fay AP; De Velasco G; Heng DY; Choueiri TK
    Cancer; 2016 Feb; 122(3):411-9. PubMed ID: 26540173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular toxicity after antiangiogenic therapy in persons older than 65 years with advanced renal cell carcinoma.
    Jang S; Zheng C; Tsai HT; Fu AZ; Barac A; Atkins MB; Freedman AN; Minasian L; Potosky AL
    Cancer; 2016 Jan; 122(1):124-30. PubMed ID: 26439451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of left ventricular motion and central augmentation index in healthy young men.
    Cheng K; Cameron JD; Tung M; Mottram PM; Meredith IT; Hope SA
    J Hypertens; 2012 Dec; 30(12):2395-402. PubMed ID: 23041752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longitudinal Assessment of Vascular Function With Sunitinib in Patients With Metastatic Renal Cell Carcinoma.
    Catino AB; Hubbard RA; Chirinos JA; Townsend R; Keefe S; Haas NB; Puzanov I; Fang JC; Agarwal N; Hyman D; Smith AM; Gordon M; Plappert T; Englefield V; Narayan V; Ewer S; ElAmm C; Lenihan D; Ky B
    Circ Heart Fail; 2018 Mar; 11(3):e004408. PubMed ID: 29664405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of low-dose atorvastatin on arterial stiffness and central aortic pressure augmentation in patients with hypertension and hypercholesterolemia.
    Kanaki AI; Sarafidis PA; Georgianos PI; Kanavos K; Tziolas IM; Zebekakis PE; Lasaridis AN
    Am J Hypertens; 2013 May; 26(5):608-16. PubMed ID: 23449607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heart Rate Dependency of Large Artery Stiffness.
    Tan I; Spronck B; Kiat H; Barin E; Reesink KD; Delhaas T; Avolio AP; Butlin M
    Hypertension; 2016 Jul; 68(1):236-42. PubMed ID: 27245180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood pressure and arterial stiffness in obese children and adolescents.
    Hvidt KN
    Dan Med J; 2015 Mar; 62(3):. PubMed ID: 25748874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymorphisms in endothelial nitric oxide synthase (eNOS) and vascular endothelial growth factor (VEGF) predict sunitinib-induced hypertension.
    Eechoute K; van der Veldt AA; Oosting S; Kappers MH; Wessels JA; Gelderblom H; Guchelaar HJ; Reyners AK; van Herpen CM; Haanen JB; Mathijssen RH; Boven E
    Clin Pharmacol Ther; 2012 Oct; 92(4):503-10. PubMed ID: 22948895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Doppler indexes of left ventricular systolic and diastolic flow and central pulse pressure in relation to renal resistive index.
    Kuznetsova T; Cauwenberghs N; Knez J; Thijs L; Liu YP; Gu YM; Staessen JA
    Am J Hypertens; 2015 Apr; 28(4):535-45. PubMed ID: 25241047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Forty-eight-hour ambulatory blood pressure and carotid-femoral pulse wave velocity in hemodialysis patients.
    Ekart R; Bernhardt M; Balon BP; Bevc S; Hojs R
    Ther Apher Dial; 2011 Jun; 15(3):273-7. PubMed ID: 21624075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meta-analysis of randomized controlled trials for the incidence and risk of treatment-related mortality in patients with cancer treated with vascular endothelial growth factor tyrosine kinase inhibitors.
    Schutz FA; Je Y; Richards CJ; Choueiri TK
    J Clin Oncol; 2012 Mar; 30(8):871-7. PubMed ID: 22312105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biological Effects After Discontinuation of VEGFR Inhibitors in Metastatic Renal Cell Cancer.
    Boers-Sonderen MJ; Desar IM; Fütterer JJ; Mulder SF; De Geus-Oei LF; Mulders PF; Van Der Graaf WT; Oyen WJ; Van Herpen CM
    Anticancer Res; 2015 Oct; 35(10):5601-6. PubMed ID: 26408732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of antihypertensive drugs on central blood pressure in humans: a preliminary observation.
    Agnoletti D; Zhang Y; Borghi C; Blacher J; Safar ME
    Am J Hypertens; 2013 Aug; 26(8):1045-52. PubMed ID: 23736112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.